KYORIN Co., Ltd. takes on the role, as the controlling company, as being responsible for the business strategies of the overall group. By effectively allocating and utilizing its managerial resources, KYORIN will draw out the strengths of the entire group and endeavor to boost the group's consolidated result.
Major Subsidiaries and Affiliates
Consolidated subsidiaries
KYORIN Pharmaceutical Co., Ltd.
| Capital | 4,317 million yen (Percentage of ownership: 100%) |
|---|---|
| Head Office | 5, Kanda Surugadai 2-chome,Chiyoda-ku, Tokyo 101-8311 Japan |
| Operations | Manufacture and sales of prescription medicines and quasi-drugs, diagnostics and industrial chemical |
| Website | http://www.kyorin-pharm.co.jp/en/ |
KYORIN Rimedio Co., Ltd.
| Capital | 1,200 million yen (Percentage of ownership: 100%) |
|---|---|
| Head Office | 287-1, Shimocho Moroe-cho, Kanazawa City, Ishikawa Prefecture 920-0017 |
| Operations | Manufacture and sales of prescription medicines and quasi-drugs, diagnostics and industrial chemical |
| Website | http://www.kyorin-rmd.co.jp/ |
Dr. Program Co., Ltd.
| Capital | 251 million yen (Percentage of ownership: 100%) |
|---|---|
| Head Office | 3rd Floor. 5-4-40, Minami-Aoyama, Minato-Ku, Tokyo 107-0062 |
| Operations | Production and sales of skincare products, pharmaceuticals and cosmetic materials |
| Website | http://www.drprogram.co.jp/ |
KYORIN Medical Supply Co., Ltd.
| Capital | 488 million yen (Percentage of ownership: 100%) |
|---|---|
| Head Office | Kyorin Nishi-Shinjuku Bldg., 6-25-13 Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-0023 |
| Operations | Sales promotion, advertising planning and production |
| Website | http://www.kyorin-ms.co.jp/ |
KYORIN Pharmaceutical Subsidiaries
Kyorin USA, Inc.
| Capital | US$500,000 (Percentage of ownership: 100%) |
|---|---|
| Head Office | 500 Frank W. Burr Boulevard, Teaneck, New Jersey 07666, United States |
| Operations | Research and analysis of other companies’ technologies and collection of information concerning clinical trials |
Kyorin Europe GmbH
| Capital | 50,000 EURO (Percentage of ownership: 100%) |
|---|---|
| Head Office | Kaiserstrasse 8, 60311 Frankfurt am Main, Germany |
| Operations | Research and analysis of other companies’ technologies and collection of information concerning clinical trials |
ActivX Biosciences, Inc.
| Capital | US$1 (Percentage of ownership: 100%) |
|---|---|
| Head Office | 11025 N. Torrey Pines Rd. La Jolla, California 92037, United States |
| Operations | Discovery and evaluation of candidate compounds |
Equity-Method Affiliates
Nippon Rika Co., Ltd.
| Capital | ¥411 million (Percentage of ownership: 29.2%) |
|---|---|
| Head Office | 2-2, Nihonbashi Honcho 4-chome, Chuo-ku, Tokyo 103-0023 |
| Operations | Production and sales of pharmaceuticals, reagents, intermediates and other products |
